scispace - formally typeset
W

Wang Zhou

Researcher at Second Military Medical University

Publications -  52
Citations -  1705

Wang Zhou is an academic researcher from Second Military Medical University. The author has contributed to research in topics: Stromal cell & Survival rate. The author has an hindex of 21, co-authored 48 publications receiving 1412 citations. Previous affiliations of Wang Zhou include Tsinghua University.

Papers
More filters
Posted ContentDOI

The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes

TL;DR: The bioinformatics evidence of the potential route for infection of 2019-nCov in digestive system along with respiratory tract is provided and may have significant impact for the authors' healthy policy setting regards to prevention of2019-nCoV infection.
Posted ContentDOI

The insert sequence in SARS-CoV-2 enhances spike protein cleavage by TMPRSS

TL;DR: The bioinformatics evidence for the increased spike protein cleavage of SARS-CoV-2 is provided and its potential target cells are indicated, including esophageal upper epithelial cells and absorptive enterocytes.
Journal ArticleDOI

Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma.

TL;DR: It is found that hypoxia may promote the expression of BCL9 and associate with the development of HCC, and specific regulation of B CL9 expression by HIF-1α may prove to be an underlying crosstalk between Wnt/β-catenin signaling and hypoxIA signaling pathways.
Journal ArticleDOI

Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center.

TL;DR: Total spondylectomy, by either en bloc or piecemeal method, could significantly reduce local relapse-free survival (LRFS) for spinal chordoma patients.
Posted ContentDOI

The transmembrane serine protease inhibitors are potential antiviral drugs for 2019-nCoV targeting the insertion sequence-induced viral infectivity enhancement

TL;DR: Transmembrane serine protease inhibitors as the antiviral treatment options for 2019-nCoV infection targeting TMPRSS2 are indicated and bioinformatics and structure evidence for the increased viral infectivity of 2019- nCoV is provided.